home / stock / pbd / pbd news

PBD News and Press, Invesco Global Clean Energy From 03/18/20

Stock Information
Company Name: Invesco Global Clean Energy
Stock Symbol: PBD
Market: NYSE
Menu
PBD PBD Quote PBD Short PBD News PBD Articles PBD Message Board
Get PBD Alerts

News, Short Squeeze, Breakout and More Instantly...
PBD - Protalix BioTherapeutics Announces Closing of $43.7 Million Private Placement

CARMIEL, Israel , March 18, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plan...
PBD - Protalix Biotherapeutics Announces Feasibility Study with Kirin Holdings on the Production of a Novel Complex Protein

CARMIEL, Israel , March 16, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® &#x...

PBD - Protalix BioTherapeutics Announces $43.7 Million in Financing to Further Advance its Programs in Fabry Disease

CARMIEL, Israel , March 12, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ®  ...

PBD - Protalix BioTherapeutics Presents Key Clinical Data of Pegunigalsidase Alfa for the Treatment of Fabry Disease at the 16th Annual WORLDSymposium(TM) 2020

CARMIEL, Israel , Feb. 10, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® pla...
PBD - Protalix BioTherapeutics and Chiesi Farmaceutici Announce Receipt of "Agreement Letter" for Initial Pediatric Study Plan for PRX-102 for the Treatment of Fabry Disease

CARMIEL, Israel , Feb. 6, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® ...

PBD - Protalix BioTherapeutics to Participate in the 2020 BIO CEO & Investor Conference and the Noble Capital Markets' 16th Annual Small & Microcap Investor Conference

CARMIEL, Israel , Feb. 4, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® p...

PBD - Protalix BioTherapeutics to Participate in the 16th Annual WORLDSymposium(TM) 2020

CARMIEL, Israel , Jan. 30, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx &#...
PBD - Most new power generating capacity in 2020 to come from wind, solar

Wind and solar power will dominate new electricity generation across the U.S. this year, according to a new forecast from the Energy Information Administration. More news on: Energy Select Sector SPDR ETF, Utilities Select Sector SPDR ETF, Invesco Solar Portfolio ETF, Energy stocks ne...

PBD - Protalix BioTherapeutics Adds Two Accomplished Biopharmaceutical Executives to its Board of Directors

CARMIEL, Israel, Dec. 19, 2019 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ...

PBD - U.N. climate talks come to an end

Sparring for two weeks in Madrid at the annual UN climate summit, delegates from nearly 200 nations failed to strengthen targets to cut emissions or to create a global carbon-trading system, two main goals of the 2015 Paris accord. More news on: iShares S&P Global Clean Energy Index ...
Previous 10 Next 10